June 29, 2016
11 am to 12 pm EDT

Sponsored by



Webinar Description:

Molecular Snapshot with Driver-Map Targeted Expression Profiling Assay. Tumor microenvironment is the current focus in cancer. Immune infiltrate in several human carcinoma types is implicated in prognosis and/or response to therapy. Molecular profiles of tumors and tumor-associated cells hold considerable promise as biomarkers of clinical outcomes. Considering each of these, Cellecta developed a novel Driver-Map portfolio—a targeted expression profiling service that leverages the power of Multiplex PCR and NGS assays and allows you to obtain transcriptome analysis of your sample. It can be used to detect cellular composition, profile immunotherapy targets and, obtain expression analysis of ~8,000 genes. Join us for this webinar to learn about technology validation and intended applications.

Learning Objectives:

  • Overview of transcriptomic approaches
  • Driver-Map technology
  • Biomarker discovery platform


Sunitha SastrySunitha Sastry, Ph.D.

Senior Product Manager

Cellecta, Inc.

Sunitha Sastry is Senior Product Manager at Cellecta (Mountain View, CA). She has over 8 years of product management experience and has commercialized many different assay platforms in the life sciences industry.